Abstract
We studied the effects of tamoxifen (TAM) on the growth of 7,12-dimethylbenz(a)anthracene (DMBA)-induced rat mammary tumor and the expression of cyclin D1, cyclin E, p21Cip1, and estrogen receptors (ER) by performing immunohistochemistry and Western blot analysis. When tumor size reached between 10 and 15 mm in the largest dimension, the rats were divided into a DMBA-control group and a DMBA-TAM group. The administration of TAM markedly decreased the tumor development and showed decreased expression of bromodeoxyuridine, cyclin D1, cyclin E, and p21Cip1 when compared with those of the DMBA-control group; however, a few tumors showed progressive growth in spite of TAM treatment. These tumors had decreased expression of ER. This study suggests that TAM suppresses tumor development through the down-expression of cyclin D1 and cyclin E.
| Original language | English |
|---|---|
| Pages (from-to) | 109-116 |
| Number of pages | 8 |
| Journal | Cancer Letters |
| Volume | 170 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2001 Sept 20 |
Bibliographical note
Funding Information:This work was supported by the Korea Research Foundation through Basic Medical Research Fund (998-021-F00137). We especially thank Moung Hee Shon and Woo Jin Juen for technical assistance.
All Science Journal Classification (ASJC) codes
- Oncology
- Cancer Research
